CareSignal
Category: AI in Healthcare
An AI-powered, deviceless remote patient monitoring (RPM) platform that uses automated SMS text messages and phone calls to manage chronic conditions and reduce hospital readmissions. CareSignal was founded in 2015. The company is led by Blake Marggraff. Based in St. Louis, United States. Team size: 51-200. Total funding raised: $17.9M. Latest round: Incubator/Accelerator, Undisclosed, 2021-09, led by Plug and Play Insurtech. Key investors include OSF Ventures, UnityPoint Health Ventures, Nueterra Capital, Cultivation Capital, 1984 Ventures.
- Founded
- 2015
- Headquarters
- St. Louis, United States
- Team size
- 51-200
- Total funding
- $17.9M
Value proposition
To proactively manage and monitor rising-risk patient populations at scale, improving clinical outcomes and reducing healthcare costs without the need for special hardware or smartphones.
Products and solutions
Deviceless Remote Patient Monitoring® (RPM), Condition-specific programs (e.g., for COPD, Congestive Heart Failure, Diabetes, Hypertension, Depression), Deviceless Remote Therapeutic Monitoring™ (RTM)
Unique value
The core innovation is its "deviceless" approach to remote patient monitoring. By using accessible technology like SMS and phone calls, it eliminates the need for patients to have smartphones, internet access, or separate medical devices, overcoming major barriers to adoption and significantly increasing patient reach and engagement.
Target customer
Healthcare providers, health systems, payers, and accountable care organizations (ACOs) operating under value-based care models.
Industries served
Healthcare, Health Insurance
Technology advantage
CareSignal's key advantage is its ability to scale engagement across large, diverse patient populations, including elderly and low-income individuals. The platform uses AI to analyze patient-reported data, identify at-risk patients for timely intervention, and even predict patient disengagement to proactively keep them enrolled in monitoring programs.
How they differentiate
CareSignal's primary differentiator is its "deviceless" remote patient monitoring (RPM) platform. Instead of requiring patients to use special hardware or smartphones, it leverages accessible technology like SMS text messages and automated phone calls. This approach removes barriers to entry for elderly and low-income populations, making it highly scalable and cost-effective for healthcare providers in value-based care models.
Main competitors
Health Recovery Solutions (HRS), Vivify Health, Validic
Key partnerships
Lightbeam Health Solutions (Acquirer), OSF HealthCare, Health Alliance, Innovaccer, Stratum Med, Texas Association of Community Health Centers (TACHC), Mankato Clinic
Notable customers
Esse Health, UnityPoint Health, OSF HealthCare, Community Care Plan of South Florida, WEA Trust
Major milestones
Successfully commercialized a deviceless remote patient monitoring platform accessible via SMS and phone calls., Validated its clinical and financial impact through more than 13 peer-reviewed studies., Secured strategic investments from the venture arms of major health systems like OSF HealthCare and UnityPoint Health., Acquired by Lightbeam Health Solutions in November 2021 to integrate its RPM capabilities into a comprehensive population health management platform.
Growth metrics
As a private company acquired by Lightbeam Health Solutions, specific growth metrics are not public. However, traction is demonstrated by its numerous partnerships and successful case studies with healthcare organizations.
Market positioning
CareSignal is positioned as a leader in patient engagement and deviceless RPM, specifically targeting health systems, payers, and accountable care organizations (ACOs) focused on value-based care. By identifying rising-risk patients through proactive engagement, it helps organizations reduce readmissions, improve chronic disease management, and lower the total cost of care. Its acquisition by Lightbeam Health Solutions integrated it into a broader population health management ecosystem.
Geographic focus
The primary geographic focus for CareSignal and its competitors is North America, particularly the United States, where the healthcare system's shift towards value-based care and reimbursement for remote monitoring services has created a strong market.
Patents and IP
Specific patent information is not publicly detailed, but their competitive advantage lies in their evidence-based engagement programs and proprietary AI algorithms.
About Blake Marggraff
Co-founder and CEO of CareSignal (originally Epharmix), a deviceless remote patient monitoring company. He led the company through its growth, rebranding, and successful acquisition by Lightbeam Health Solutions in 2021.
Official website: https://lightbeamhealth.com/caresignal/